These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24951469)

  • 21. Microengineered vascular systems for drug development.
    Hovell CM; Sei YJ; Kim Y
    J Lab Autom; 2015 Jun; 20(3):251-8. PubMed ID: 25424383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin diseases in laboratory mice: approaches to drug target identification and efficacy screening.
    Sundberg JP; Silva KA; McPhee C; King LE
    Methods Mol Biol; 2010; 602():193-213. PubMed ID: 20012400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
    Wang YI; Carmona C; Hickman JJ; Shuler ML
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin bioengineering: preclinical and clinical applications.
    Martínez-Santamaría L; Guerrero-Aspizua S; Del Río M
    Actas Dermosifiliogr; 2012 Jan; 103(1):5-11. PubMed ID: 22464599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Strategies and Future Perspectives of Skin-on-a-Chip Platforms: Innovations, Technical Challenges and Commercial Outlook.
    Bal-Öztürk A; Miccoli B; Avci-Adali M; Mogtader F; Sharifi F; Çeçen B; Yaşayan G; Braeken D; Alarcin E
    Curr Pharm Des; 2018; 24(45):5437-5457. PubMed ID: 30727878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of cutaneous sulfur mustard injuries.
    Graham JS; Stevenson RS; Mitcheltree LW; Hamilton TA; Deckert RR; Lee RB; Schiavetta AM
    Toxicology; 2009 Sep; 263(1):47-58. PubMed ID: 18762227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microprinting of liver micro-organ for drug metabolism study.
    Chang RC; Emami K; Jeevarajan A; Wu H; Sun W
    Methods Mol Biol; 2011; 671():219-38. PubMed ID: 20967633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Skin-on-a-Chip Technologies for Dermatological Disease Modeling.
    Cho SW; Malick H; Kim SJ; Grattoni A
    J Invest Dermatol; 2024 Aug; 144(8):1707-1715. PubMed ID: 38493383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tissue culture of human skin--a review of experimental methods and applications to dermatologic problems].
    Yasuno H; Yamanishi K
    Hum Cell; 1988 Jun; 1(2):162-70. PubMed ID: 2856497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous tissue engineering and lower extremity wounds (part 2).
    Dini V; Romanelli M; Piaggesi A; Stefani A; Mosca F
    Int J Low Extrem Wounds; 2006 Mar; 5(1):27-34. PubMed ID: 16543210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin tissue engineering--in vivo and in vitro applications.
    Groeber F; Holeiter M; Hampel M; Hinderer S; Schenke-Layland K
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):352-66. PubMed ID: 21241756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioengineered human gut-on-a-chip for advancing non-clinical pharmaco-toxicology.
    Shin YC; Than N; Park SJ; Kim HJ
    Expert Opin Drug Metab Toxicol; 2024 Jul; 20(7):593-606. PubMed ID: 38849312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models.
    Patel B; Gauvin R; Absar S; Gupta V; Gupta N; Nahar K; Khademhosseini A; Ahsan F
    Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(9):L733-47. PubMed ID: 22886505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin.
    Llames SG; Del Rio M; Larcher F; García E; García M; Escamez MJ; Jorcano JL; Holguín P; Meana A
    Transplantation; 2004 Feb; 77(3):350-5. PubMed ID: 14966407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
    Low LA; Tagle DA
    Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioengineered models of cardiovascular diseases.
    Chandra Sekar N; Khoshmanesh K; Baratchi S
    Atherosclerosis; 2024 Jun; 393():117565. PubMed ID: 38714426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered tissues and strategies to overcome challenges in drug development.
    Khalil AS; Jaenisch R; Mooney DJ
    Adv Drug Deliv Rev; 2020; 158():116-139. PubMed ID: 32987094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NIH microphysiological systems program: developing in vitro tools for safety and efficacy in drug development.
    Tagle DA
    Curr Opin Pharmacol; 2019 Oct; 48():146-154. PubMed ID: 31622895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved in vitro models for preclinical drug and formulation screening focusing on 2D and 3D skin and cornea constructs.
    Beißner N; Bolea Albero A; Füller J; Kellner T; Lauterboeck L; Liang J; Böl M; Glasmacher B; Müller-Goymann CC; Reichl S
    Eur J Pharm Biopharm; 2018 May; 126():57-66. PubMed ID: 29191717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.